HHS Announces Additional Million Doses of Flu Vaccine
WASHINGTON -- HHS Secretary Tommy G. Thompson announced yesterday that the nation will have an additional 1 million doses of the FluMist nasal spray flu vaccine, bringing the total flu vaccine supply this year to 61 million doses. Additionally, there is enough antiviral medicine to treat tens of millions of people for flu this season.
MedImmune, the maker of FluMist, notified Secretary Thompson of the additional doses of the nasal spray vaccine. With the new doses, the nation will have 3 million doses of FluMist, which is approved for use for healthy people between the ages of five and 49 years -- including some people in the priority categories, such as health care workers.
We have healthy supplies of antiviral medicines and vaccines to help keep you safe from the flu and any complications, Thompson said. The combination of the existing 61 million doses of vaccine and antiviral medicines gives us the capability to cope with this years flu season, even if it turns out to be a severe season.
Secretary Thompson said the supply of 61 million doses of flu vaccine includes about 58 million doses of Aventis injectible vaccine and 3 million doses of FluMist nasal spray. There is some potential that more doses may be secured from other sources.
Additionally, Thompson said seniors shouldnt stand in long lines to wait for the vaccine because Aventis Pasteur is shipping an average of up to 3 million doses of vaccine each week to health care providers around the country.
We dont want seniors standing in long lines waiting for the vaccine. This is unnecessary and may pose even greater health risks for some seniors than the flu, Thompson said. We are still in the early stages of the flu season, and millions more doses of vaccine will be shipped in the coming weeks. There is still time to get vaccinated.
Aventis Pasteur is shipping vaccine each week to health care providers throughout the country who serve the high-priority groups recommended by the Centers for Disease Control and Prevention (CDC) to receive influenza vaccine during the 2004-2005 season. Last week, flu vaccine was sent to the Veterans Administration, long-term care facilities and acute care hospitals, state public health officials, the Vaccines for Children program, and private providers who care for young children.
Secretary Thompson stressed that the influenza vaccine needs to go to those who are most vulnerable and called on those not in priority groups to forgo a vaccine this year. Those in the priority categories include:
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
